Aqueous Humor VEGF Levels Up With Prostaglandin for Glaucoma

Share this content:
Aqueous Humor VEGF Levels Up With Prostaglandin for Glaucoma
Aqueous Humor VEGF Levels Up With Prostaglandin for Glaucoma

FRIDAY, Dec. 30, 2016 (HealthDay News) -- Vascular endothelial growth factor (VEGF) levels are significantly higher in the aqueous humor of diabetes mellitus (DM) patients and glaucoma patients who used prostaglandin agents, according to a letter to the editor published online Dec. 23 in Clinical & Experimental Ophthalmology.

Jin-woo Kwon, M.D., and Donghyun Jee, M.D., Ph.D., from the Catholic University of Korea in Suwon, compared levels of VEGF in the aqueous humors of 16 cataract patients without ocular disease (control group) with those of 12 patients with DM and 17 patients with glaucoma.

The researchers found that the VEGF levels differed significantly among the groups (P = 0.003). Compared with the control group, VEGF level was significantly higher in the DM group (P = 0.001) and in the glaucoma group (P = 0.015). There were significant associations between the levels of VEGF versus DM (P = 0.036) and axial length (P = 0.029), in univariate analyses. Significant associations were found in regression analysis between levels of VEGF and DM (P = 0.003) and prostaglandin agent use (P = 0.017).

"In summary, we showed increased VEGF concentrations in the aqueous humor of DM patients and glaucoma patients who used prostaglandin agents," the authors write. "However, it was unclear whether they played positive or negative roles in these patients. This will need to be decided by additional studies with larger cohorts."

Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Approves Zejula for Certain Female Cancers

FDA Approves Zejula for Certain Female Cancers

PARP inhibitor may help fight tumors affecting the ovaries, fallopian tubes, or peritoneum

USPSTF: Evidence Lacking for Celiac Dz Screen in Asymptomatic

USPSTF: Evidence Lacking for Celiac Dz Screen in ...

Insufficient evidence for weighing benefits, harms of screening for celiac disease in asymptomatic

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Lap, Abdominal Hysterectomy Equal for Early Endometrial CA

Equivalent disease-free survival at 4.5 years for stage I endometrial cancer with TAH, TLH

is free, fast, and customized just for you!

Already a member?

Sign In Now »